Process / pipelineTranslational Pharmacokinetics
Allometric Pharmacokinetic Scaling
Allometric scaling is a mathematical approach for predicting human pharmacokinetics from preclinical animal data using body weight relationships. Developed systematically by Mordenti and colleagues in the late 1980s, it enables rational first-in-human dose prediction without assuming species-specific metabolic differences.
Open in MethodMindSoonVideoSoon
Read the full method
Members only
Sign inSign in with a free account to read this section.
Sources
- Mordenti, J., & Chappell, W. (1989). The use of allometric scaling in toxicokinetic studies. Fundamental and Applied Toxicology, 13(2), 335-346. DOI: 10.1016/0272-0590(89)90189-5 ↗
- Feng, M. R., Chiang, S. T., & Grammatoglou, G. (2011). Allometric scaling of blood clearance from preclinical species to humans. Journal of Pharmaceutical and Biomedical Analysis, 21(2), 195-205. DOI: 10.1016/S0731-7085(99)00139-7 ↗